CannLabs Announces Science Advisory Board Members
June 24 2014 - 8:15AM
Marketwired
CannLabs Announces Science Advisory Board Members
DENVER, CO--(Marketwired - Jun 24, 2014) - Following its
successful public launch, CannLabs, Inc., (OTCQB: SDSPD) announced
members of its Science Advisory Board, Dr. Margaret Gedde, M.D.,
Ph.D. and Dr. Paul Matthews, Ph.D.
CannLabs has been at the forefront of educating the public, in
addition to state and local governments as more states legalize
marijuana for various uses. The board helps validate the company's
scientific methodologies as it relates to cannabis testing and
regularly meets with the management team to provide perspective on
other related areas. The company expects to announce additional
members to the Science Advisory Board over the coming months.
Dr. Margaret Gedde, M.D., Ph.D. Dr. Gedde is a Stanford trained
pathologist and award winning researcher who worked in the
pharmaceutical industry for four years. She has operated a
holistic, integrative practice since 2004.
Dr. Gedde has been focused on medical cannabis since 2009, and
helps patients with chronic pain, nausea, seizures and other
conditions while improving the quality of their lives. She is the
founder of the Clinicians' Institute for Cannabis Medicine and
medical director of Vibrant Health Clinic.
Dr. Paul Matthews, Ph.D. Dr. Matthews has a Ph.D. in plant
molecular biology and 20 years of research experience in both
academia and industry. He currently is developing genomic
strategies for applied evolution of medicinal crops. He is the
author of more than 30 peer-reviewed publications, patents and
invited book chapters.
Dr. Matthews has been president of the Hop Research Council and
is the Vice Chairman of the National Clean Plant Network Hops.
ABOUT CANNLABS
CannLabs, Inc., is a solutions provider with intellectual
property, proprietary cloud-based analytics and scientific methods
to serve the cannabis industry. Through Carbon Bond Holdings Inc.,
CannLabs provides laboratories with the necessary business
intelligence technology and other solutions required to serve the
cannabis industry, and these include the first state-licensed
laboratory in Denver, Colorado.
CannLabs enables growers, dispensaries and edible makers to
implement best practices while furthering product advancements. In
addition, the CannLabs website allows consumers to easily locate
certified tested products to meet their specific needs.
CannLabs has been at the forefront of educating the public, in
addition to state and local governments as more states legalize
marijuana for various uses. The Company provides client education
around safe cultivation, identifying contamination problems,
consulting on legal cases and the reformulation of cannabis
products, throughout the U.S. and Canada.
The Company plans to license their solutions to new labs and
other cannabis companies in states and provinces as legislation and
testing mandates for legalization are approved. This will allow the
Company to further scale its data analytics and consulting business
across a broader geographic area. In addition, the CannLabs team
will focus on research and development which will further drive
value for their customers and provide incremental revenue
opportunity.
For more information visit www.cannlabs.com.
Safe Harbor Statement All statements herein other than
statements of historical facts are forward-looking statements
within the meaning of the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995. These statements are
based upon our current expectations and speak only as of the date
hereof. Such statements are not guarantees of future performance
and are subject to known and unknown risks and uncertainties that
could cause our actual results to differ materially from those
expressed or implied in such forward-looking statements. Such
factors include, but are not limited to, our ability to raise
additional capital, our limited operating history and revenue, our
ability to attract and retain qualified personnel, our ability to
develop new services, market acceptance of our services,
legislative, regulatory and competitive developments in our
industry, general economic conditions, as well as other factors set
forth in our filings with the SEC.
CONTACT: Company Robert Farrell Vice President of Marketing
855-842-6936 robert.farrell@cannlabs.com www.cannlabs.com Investor
Relations Matt Hayden Chairman MZ North America 949-259-4986
matt.hayden@mzgroup.us www.mzgroup.us
CannLabs (CE) (USOTC:CANL)
Historical Stock Chart
From Oct 2024 to Nov 2024
CannLabs (CE) (USOTC:CANL)
Historical Stock Chart
From Nov 2023 to Nov 2024
